Round led by PXN Ventures, with additional funding from existing investors IQ Capital and Northern Gritstone * Company uses quantum physics, AI m ...

The company's closed-loop platform is designed to dramatically speed up enzyme development for pharmaceuticals, sustainable ...

Part II asks what happens when we carry that insight forward — into the relationship between human minds and artificial ...

Round led by PXN Ventures, with additional funding from existing investors IQ Capital and Northern Gritstone Company uses quantum physics, AI modelling and deeply integrated laboratory automation ...

A Manchester-based techbio company using AI and quantum physics to engineer better enzymes faster, has closed a £5 million ...

The difference in perspectives between superpowers is shaping the race for A.I. dominance.

Class Disrupted is an education podcast featuring author Michael Horn and Futre’s Diane Tavenner in conversation with ...

Manchester techbio spin-out Imperagen has secured £5m in seed funding to scale an AI-powered enzyme engineering platform born out of research at The University of Manchester. The round was led by PXN ...

Earnings call Recursion Pharmaceuticals delivered strong operational progress with a 30% YoY reduction in operating expenses and an extended cash runway into early 2028. Clinical momentum was ...

This voice experience is generated by AI. Learn more. This voice experience is generated by AI. Learn more. logos of OpenAI There’s interesting news coming from Sam Altman’s empire, a firm known for ...

New York Post may be compensated and/or receive an affiliate commission if you click or buy through our links. Featured pricing is subject to change. Are your ears under assault? In today’s world, it ...

Below is an edited transcript of an episode of “Interesting Times.” We recommend listening to it in its original form for the ...